{"text": "Non - inferiority trials are clearly appropriate for some diseases and some treatments .This would only happen if the lower bound of the interval were above zero , not simply above -\u0394. Thus far , the problem sounds straightforward .", "label": "", "metadata": {}, "score": "48.31774"}
{"text": "They are also used to show lot consistency in vaccine trials , in which the outcome is a measure of immune response .Non - inferiority is different from equivalence .", "label": "", "metadata": {}, "score": "51.23341"}
{"text": "By contrast , a non - inferiority trial without assay sensitivity may generate a positive result ( that is , it may show evidence of non - inferiority ) if it shows no difference between the treatment groups , as this would lead to a conclusion of non - inferiority .", "label": "", "metadata": {}, "score": "53.033604"}
{"text": "Rothmann MD , Tsou HH : On non - inferiority analysis based on delta - method confidence intervals .J Biopharm Stat 2003 , 13 : 565 - 583 .", "label": "", "metadata": {}, "score": "54.318985"}
{"text": "If it sits wholly above -\u0394 , then it has shown non - inferiority .A non - inferiority trial can have five possible types of outcomes as depicted in Figure 2 .", "label": "", "metadata": {}, "score": "56.826294"}
{"text": "In the inverted world of non - inferiority , the alternative hypothesis seems ' null ' , whereas the null hypothesis includes a specified treatment difference of -\u0394. Here , -\u0394 is an integral part not only of the design , as with \u03b3 in superiority trials , but of the analysis as well , a role that \u03b3 does not play in superiority trials .", "label": "", "metadata": {}, "score": "57.58889"}
{"text": "Equivalence was defined as a difference of no more than five percentage points in seroconversion rates , and ratio between Geometric Mean Titters ( GMT ) higher than 0.67 .", "label": "", "metadata": {}, "score": "59.07402"}
{"text": "One focuses on the lower bound for this non - inferiority comparison ; what happens at the upper end of the CI is not the primary concern .", "label": "", "metadata": {}, "score": "59.310005"}
{"text": "Superiority , equivalence , and non - inferiority .Investigators understand intuitively , even before applying statistical rigor , how to conduct a trial to establish superiority of a novel treatment .", "label": "", "metadata": {}, "score": "59.524574"}
{"text": "Although non - inferiority trials are often conceptually desirable , operational difficulties may plague the process of choosing the margin , either because of insufficient data to support a selected margin or a calculated margin that leads to an impractical sample size .", "label": "", "metadata": {}, "score": "60.04622"}
{"text": "As a non - inferiority trial , however , such a flawed trial would be very likely to incorrectly demonstrate non - inferiority .Others [ 4 ] ( including the authors ) disagree with that opinion .", "label": "", "metadata": {}, "score": "60.163216"}
{"text": "A 10 % benefit , corresponding to a proportion of 55 % in the new treatment , would require a sample size of just over 500 per group to show non - inferiority .", "label": "", "metadata": {}, "score": "60.35498"}
{"text": "Having agreed to analyze both the ITT population and some version of a PP population , and having selected the appropriate active control , an investigator next must select the non - inferiority margin and method of analysis .", "label": "", "metadata": {}, "score": "60.376545"}
{"text": "In a non - inferiority trial , by contrast , the aim is to show that a new product is not unacceptably worse than an older one .", "label": "", "metadata": {}, "score": "60.473465"}
{"text": "The choice of the non - inferiority margin and how much of the existing treatment effect to preserve incorporates in some sense these other aspects of treatment ' viability ' .", "label": "", "metadata": {}, "score": "61.06806"}
{"text": "Whether a Delphic method , the synthesis method , or the 95 - 95 approach is used , the first step in defining the non - inferiority margin is to gather all relevant information about the effect of the active control .", "label": "", "metadata": {}, "score": "61.095554"}
{"text": "At present , however , success in a non - inferiority trial in the USA depends upon success in the primary outcome measure , not on other aspects of benefit , such as safety , and regulatory success using non - inferiority trial designs may require completion of more than one such trial .", "label": "", "metadata": {}, "score": "63.331"}
{"text": "Concerns about non - inferiority trials .Non - inferiority trials have a host of complications .A serious concern , as briefly described above , is assay sensitivity , the ability of a trial to distinguish an effective therapy from one that is not effective , and the issues differ for non - inferiority trials and superiority trials .", "label": "", "metadata": {}, "score": "63.721176"}
{"text": "EMA Committee for Medicinal Products for Human Use ( CHMP ) : Guideline on the Choice of the Non - inferiority Margin London .Snappin S , Jiang Q : Controlling the type 1 error rate in non - inferiority trials .", "label": "", "metadata": {}, "score": "63.85143"}
{"text": "These are still , however , relatively modest improvements over the effect of active control , and although the sample size reductions when assuming these benefits are non - trivial , they are not so large as to suggest switching to a superiority trial to prove these benefits .", "label": "", "metadata": {}, "score": "64.29271"}
{"text": "Conventional wisdom suggests that in a non - inferiority trial , the primary population for analysis should be the per - protocol ( PP ) population , which in this case is the set of people who have taken their assigned treatment and adhered to it .", "label": "", "metadata": {}, "score": "64.97519"}
{"text": "By contrast , the synthesis method does not define a specific margin or effect of the active control based on past trials .The most important assumption here is that the effect of the active control has remained relatively constant ( or can be modeled as discussed above ) from the past into the current non - inferiority trial .", "label": "", "metadata": {}, "score": "65.28853"}
{"text": "GMT from the whole cohort were very close to GMT obtained in per protocol analysis .The intraclass correlation coefficient ( ICC ) for antibody titters in two aliquots of the same sera was 0.79 ( 95 % CI : 0.74 - 0.83 ) .", "label": "", "metadata": {}, "score": "65.55665"}
{"text": "Sample size for a non - inferiority trial is usually calculated under the assumption that the experimental agent and control treatment have equal effects , that is , when \u03b3 is assumed to be zero .", "label": "", "metadata": {}, "score": "65.59902"}
{"text": "The reason such a switch is permissible stems from the fact that we can view the test as an interpretation of a CI .The calculated CI does not know whether its purpose is to judge superiority or non - inferiority .", "label": "", "metadata": {}, "score": "67.01561"}
{"text": "The converse ( testing first for superiority and then for non - inferiority ) is not always a closed procedure .Testing in that order could lead to apparently anomalous results , even when examining a single CI .", "label": "", "metadata": {}, "score": "67.0972"}
{"text": "Thus the null hypothesis seems backwards , in a sense , as this hypothesis is not ' null ' at all .Instead , it states that the new treatment is worse than the old by more than -\u0394 , where -\u0394 is the ' non - inferiority margin ' .", "label": "", "metadata": {}, "score": "67.216484"}
{"text": "For a one - sided , non - inferiority equivalence trial it was appropriate to calculate the differences in seroconversion rates among the vaccine groups , and the ratios of GMT , with appropriate 90 % confidence interval ( 90 % CI ) set by the conventional value of 0.05 for a - error .", "label": "", "metadata": {}, "score": "67.35509"}
{"text": "The Guidance notes that in certain settings , it may be reasonable to demonstrate only non - inferiority to the M 1 margin .Such a result shows that the test drug has a non - zero effect , but that effect may not be clinically meaningful .", "label": "", "metadata": {}, "score": "67.42029"}
{"text": "As alluded to above , a variety of reasons may render a non - inferiority trial unfeasible .A rigorously calculated margin could yield a sample size that can not be supported financially or by the potential study population .", "label": "", "metadata": {}, "score": "67.6684"}
{"text": "By contrast , non - inferiority trials tend to reward the careless .The less rigorously conducted the trial , the easier it can be to show non - inferiority .", "label": "", "metadata": {}, "score": "67.92877"}
{"text": "This paper introduces concepts related to non - inferiority , and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration .", "label": "", "metadata": {}, "score": "68.36165"}
{"text": "Reversing the null and alternative hypotheses may be the first looking - glass problem of non - inferiority , but as we peer deeper , the backwardness seems to multiply !", "label": "", "metadata": {}, "score": "68.61156"}
{"text": "The CI at the top of the figure sits wholly above zero ; a trial with this outcome would conclude that the new treatment is superior and hence , also non - inferior , to the control .", "label": "", "metadata": {}, "score": "69.15053"}
{"text": "Thus , the first step in performing a meta - analysis is to collect the group of studies to use .When designing a non - inferiority trial , under ideal conditions the investigator would select a set of studies that includes only randomized trials comparing the control intervention with placebo .", "label": "", "metadata": {}, "score": "69.34645"}
{"text": "Rothmann M , Li N , Chen G , et al .: Design and analysis of non - inferiority mortality trials in oncology .Stat Med 2003 , 22 : 239 - 264 .", "label": "", "metadata": {}, "score": "69.35017"}
{"text": "The preselected \u03b3 plays no formal statistical role in the analysis of a superiority trial , although the difference in magnitude between the hypothesized \u03b3 and the estimated effect is likely to influence how to interpret the results .", "label": "", "metadata": {}, "score": "69.36908"}
{"text": "The main focus of the Guidance comes in section IV : ' Choosing the non - inferiority margin and analyzing the results of an NI trial ' .", "label": "", "metadata": {}, "score": "70.16938"}
{"text": "This property is often subverted by saying that these tests require that the studies have the same true effect size , or that they are ' fixed effects models . '", "label": "", "metadata": {}, "score": "70.37414"}
{"text": "If the lower bound is above the margin -\u0394 , the new treatment is deemed non - inferior , and the trial is a ' success ' .", "label": "", "metadata": {}, "score": "70.654366"}
{"text": "Consider , for example , a comparison of two proportions as illustrated in Table 2 .Table 2 .Approximate sample sizes required for non - inferiority comparison of proportions .", "label": "", "metadata": {}, "score": "70.78523"}
{"text": "( The check in a superiority trial is showing that the tested intervention is superior to control . )The EMA , in an effort to mitigate this problem , has suggested that non - inferiority trials , wherever possible , include a placebo arm to allow a direct comparison of both the active control and experimental agent with placebo .", "label": "", "metadata": {}, "score": "71.277306"}
{"text": "View Article .Snappin S , Jiang Q : Preservation of effect and the regulatory approval of new treatments on the basis of non - inferiority trials .", "label": "", "metadata": {}, "score": "71.73494"}
{"text": "Although challenging , such circumstances offer opportunity to the creative trialist ( and statistician ) .Conclusions .A non - inferiority trial is reasonable when a new treatment has some property sufficiently favorable that physicians , and their patients , would be willing to sacrifice some degree of benefit relative to an already approved therapy .", "label": "", "metadata": {}, "score": "71.90008"}
{"text": "A panel of clinical experts with knowledge of existing treatment options and underlying disease may be able to consider trade - offs on the level of the patient population , and could propose a plausible non - inferiority margin .", "label": "", "metadata": {}, "score": "71.99702"}
{"text": "Complications - other than the margin .Among the challenges in non - inferiority trials compared with superiority trials are the choices of the margin , the primary population for analysis , and the comparator treatment .", "label": "", "metadata": {}, "score": "72.0475"}
{"text": "Sufficient data need to be available to allow calculation of the non - inferiority margin for the same disease and endpoint .The FDA Guidance [ 6 ] does allow , however , that the active control need not be approved for the indication of interest in the non - inferiority trial if these data exist .", "label": "", "metadata": {}, "score": "72.380264"}
{"text": "Sample size was based on a null hypothesis of non - equivalence and alternative hypothesis of equivalence .1 Epi Info 6.04c and SPSS 10 , 1999 were used for data entry and statistical analysis .", "label": "", "metadata": {}, "score": "72.455765"}
{"text": "An investigator may also have several choices for the comparator arm in a non - inferiority trial , but it must be a ' fair fight ' .", "label": "", "metadata": {}, "score": "72.48409"}
{"text": "This is like a KS law , but for individual GMCs .Chen et al .( 2010 ) studied the KS relation for individual GMCs in the LMC .", "label": "", "metadata": {}, "score": "72.77367"}
{"text": "Many appeal to the PP population in a non - inferiority trial because the more poorly run a trial , the more likely an ITT analysis will show non - inferiority .", "label": "", "metadata": {}, "score": "73.08793"}
{"text": "PubMed View Article .EMA Committee for Proprietary Medicinal Products ( CPMP ) : Points to Consider on Switching between Superiority and Non - inferiority London .", "label": "", "metadata": {}, "score": "73.93254"}
{"text": "Links ] .Tauraso NM , Myers MG , Nau EV , O'Brien TC , Spindel SS , Trimmer RW .Effect of interval between inoculation of live smallpox and yellow - fever vaccines on antigenicity in man .", "label": "", "metadata": {}, "score": "74.23134"}
{"text": "Another stems from biocreep .Suppose an earlier trial found drug A to be clearly better than placebo , then several years later , drug B is found non - inferior to drug A in a trial with a large non - inferiority margin .", "label": "", "metadata": {}, "score": "74.40652"}
{"text": "Na coorte completa ( incluindo os previamente soropositivos ) a soroconvers\u00e3o foi igual ou superior a 90 % .As diferen\u00e7as na soroconvers\u00e3o variaram de -0,05 % a -3,02 % entre os grupos de compara\u00e7\u00e3o .", "label": "", "metadata": {}, "score": "74.48965"}
{"text": "Sometimes , the goal is not to show that the new treatment is better , but that the new treatment is ' equivalent ' to the control .", "label": "", "metadata": {}, "score": "74.99133"}
{"text": "This calculation typically uses meta - analytic methods with data from previous studies , as we describe below , to obtain a 95 % CI around the estimated difference between the active control and placebo .", "label": "", "metadata": {}, "score": "75.46741"}
{"text": "Anticorpos neutralizantes contra febre amarela foram dosados antes e depois da vacina\u00e7\u00e3o .Definiu - se equival\u00eancia como diferen\u00e7a nas taxas de soroconvers\u00e3o n\u00e3o superior a cinco pontos percentuais , e raz\u00e3o de t\u00edtulos m\u00e9dios geom\u00e9tricos superior ( TMG ) a 0,67 .", "label": "", "metadata": {}, "score": "75.90361"}
{"text": "But as difficult and counterintuitive as classical statistics may be , they are simple compared with the problems of inference in non - inferiority trials .", "label": "", "metadata": {}, "score": "76.004135"}
{"text": "Analysis considering only those seronegative to YF in the pre - vaccination test ( per protocol analysis ) showed excellent immunogenicity of the vaccines .The differences between proportions of seroconversion were never beyond 3 % , but for some contrasts , the 90 % CI included values outside the range defining equivalence .", "label": "", "metadata": {}, "score": "76.054565"}
{"text": "Such weighting may be inappropriate ; small studies are often conducted at a single center , and are more likely to be subject to bias and less likely to have had rigorous checking of data quality or the use of rigorous methods in study conduct .", "label": "", "metadata": {}, "score": "76.31601"}
{"text": "But wait !There 's more !Non - inferiority trials also face the issue of ' assay sensitivity ' , the reality that , in some disease settings , even truly effective drugs do not always show benefit in a clinical trial .", "label": "", "metadata": {}, "score": "76.32795"}
{"text": "Next , a smaller margin , M 2 , is specified in order to preserve some predetermined fraction of the estimated active control effect , for example , 50 or 75 % .", "label": "", "metadata": {}, "score": "77.20413"}
{"text": "Differences in seroconversion ranged from -0.05 % to -3.02 % .The intensity of the immune response was also very similar across vaccines : 14.5 to 18.6 IU / mL. GMT ratios ranged from 0.78 to 0.93 .", "label": "", "metadata": {}, "score": "77.20932"}
{"text": "Anti - PRP GMT increased from 0.35 to 47.01 \u00b5g / ml .CONCLUSIONS : Antibody persistence following priming was satisfactory .Affiliated with .Abstract .", "label": "", "metadata": {}, "score": "77.30698"}
{"text": "PubMed View Article .Fleming TR : Current issues in non - inferiority trials .Stat Med 2008 , 27 : 317 - 332 .PubMed View Article .", "label": "", "metadata": {}, "score": "77.33071"}
{"text": "It was ethically acceptable since the study area has been free of YF , and immunization was not routinely conducted there .Two independent reviewers examined the study protocol and the preliminary results and reported to the steering committee .", "label": "", "metadata": {}, "score": "77.51149"}
{"text": "Nevertheless , the assumed advantage of the active control over placebo must also be present in the current study , even if the advantage is not directly observed .", "label": "", "metadata": {}, "score": "77.69655"}
{"text": "In this case , the single CI can be used to say that the new treatment is simultaneously ' non - inferior ' and ' inferior ' .", "label": "", "metadata": {}, "score": "77.837326"}
{"text": "Krumholz et al .( 2008 ) assume that the cold neutral density comes from two phase equilibrium .Then n scales with E 0 and becomes nearly constant .", "label": "", "metadata": {}, "score": "78.01963"}
{"text": "Seroconversion was defined as doubling of pre - vaccination antibody titters and as seropositivity among individuals with seronegative results in the pre - vaccination test .", "label": "", "metadata": {}, "score": "78.32565"}
{"text": "The lowest confidence limit of -7 % in the difference between the new seed - lot and the WHO seed - lot represented the worst scenario of the complete cohort with substantial proportion of individuals less likely to show immunological response to vaccination .", "label": "", "metadata": {}, "score": "78.47374"}
{"text": "IgG geometric mean concentrations ( GMCs ) in the PCV13+DTaP group were lower than but noninferior to the PCV7+DTaP group GMCs .The majority of subjects achieved prespecified antibody levels to DTaP antigens .", "label": "", "metadata": {}, "score": "78.66342"}
{"text": "The third interval , which straddles both zero and -\u0394 , represents a trial that has shown neither non - inferiority nor superiority .The fourth CI illustrates the case discussed above ; tucked between the two vertical lines , it shows both non - inferiority ( because it lies wholly above the line for -\u0394 ) and inferiority ( because it also lies wholly below zero ) .", "label": "", "metadata": {}, "score": "78.71486"}
{"text": "Differences in seroconversion ranged from -0.05 % to -3.02 % ( Figure 2 ) .The lower limit of the 90 % confidence interval of the difference between 17DD vaccines and the 17D vaccine was beyond the limit of equivalence .", "label": "", "metadata": {}, "score": "79.028366"}
{"text": "PubMed .Wittes J : Active - control trials : a linguistic problem .International Chinese Stat Assoc Bulletin 2001 , 39 - 40 .Wiens BL , Zhao W : The role of intention to treat in analysis of noninferiority studies .", "label": "", "metadata": {}, "score": "79.280594"}
{"text": "In practice , limitations of available data often force investigators to compromise on some of these criteria .The populations studied in the previous trials may differ in important ways from the population planned for the new trial .", "label": "", "metadata": {}, "score": "79.315285"}
{"text": "Despite a virtual disappearance of PCV7 serotypes over time , the overall pneumococcal carriage rate remained unchanged .Although others have reported an increase in PCV13 serotypes following PCV7 vaccination , only non - PCV13 serotypes were observed to have increased in this study .", "label": "", "metadata": {}, "score": "80.39675"}
{"text": "The Guidance concludes with responses to a series of questions commonly asked about non - inferiority trials and some examples .The questions concentrate on the choice of margin and the distinction between M 1 and M 2 , the suitability of the active control , and options when a non - inferiority trial is not feasible .", "label": "", "metadata": {}, "score": "80.47157"}
{"text": "The benefit given up in exchange for these advantages , however , should not be so large that patients and physicians are not willing to use the new product .", "label": "", "metadata": {}, "score": "80.742035"}
{"text": "NCT01200368 .[ Show abstract ] [ Hide abstract ] ABSTRACT : We constructed a new real - time PCR method to detect causative pathogens in cerebrospinal fluid ( CSF ) from patient due to bacterial meningitis .", "label": "", "metadata": {}, "score": "80.759125"}
{"text": "Authors ' Affiliations .Statistics Collaborative , Inc. .References .Temple R , Ellenberg SS : Placebo - controlled trials and active - control trials in the evaluation of new treatments ; Part 1 : Ethical and scientific issues .", "label": "", "metadata": {}, "score": "80.8426"}
{"text": "As the EMA Guidance document stresses , both statistical and clinical judgment should play into the choice of margin .M 1 is calculated , as described above , as the lower end of the 95 % CI around the best estimate of the effect size of the control group relative to placebo .", "label": "", "metadata": {}, "score": "80.90307"}
{"text": "The M 2 does provide some room for flexibility by varying the proportion of the active control effect that is preserved .For serious diseases with known and highly effective treatments , any new product would need to preserve a large amount of the known treatment effect to be considered successful .", "label": "", "metadata": {}, "score": "81.49321"}
{"text": "Reduction of IPD caused by VT strains was accomplished , but a rapid increase of NVT raises concern about a future decrease in the efficacy of PCV7 .", "label": "", "metadata": {}, "score": "81.58716"}
{"text": "This test , sitting on the other side of the looking glass , requires an interpretation different from the usual .In some trials , it is statistically appropriate to perform a superiority comparison first and , if that does not show statistical benefit , to perform a non - inferiority comparison .", "label": "", "metadata": {}, "score": "81.692"}
{"text": "The age of participants ranged from 14.8 to 67.7 years , with comparable means and standard deviations across groups ( Table 1 ) .Young males were highly predominant .", "label": "", "metadata": {}, "score": "81.73367"}
{"text": "There is a linear part at high column density and a steeper part at low column density .Leroy et al .( 2008 ) compared these new survey results to various theoretical models .", "label": "", "metadata": {}, "score": "81.74504"}
{"text": "These results were somewhat independent of galaxy mass .The molecular / atomic ratio also scaled with pressure in an approximately linear fashion , regardless of galaxy mass , as observed .", "label": "", "metadata": {}, "score": "82.43857"}
{"text": "The inter - rater agreement of antibody titters was assessed through independent tests performed in duplicate serum aliquots in a 20 % sub - sample of participants .", "label": "", "metadata": {}, "score": "82.56731"}
{"text": "The Guidance provides useful notation , which we have adopted for our discussion in this paper .As described above , we use M 1 to denote the entire effect the active control has relative to placebo , and M 2 to denote the largest loss of effect ( inferiority ) that would be clinically acceptable when comparing the test drug with the active control .", "label": "", "metadata": {}, "score": "82.60149"}
{"text": "In fact , we can refer back to Figure 2 and see how the confidence limit compares with the limits shown in the figure .Sample size .", "label": "", "metadata": {}, "score": "82.76778"}
{"text": "OBJETIVO : Comparar a imunogenicidade de tr\u00eas vacinas contra febre amarela ) das subcepas WHO-17D e 17DD brasileira ( diferentes lotes - semente ) .M\u00c9TODOS : Trata - se de ensaio de equival\u00eancia envolvendo 1.087 adultos no Rio de Janeiro , RJ .", "label": "", "metadata": {}, "score": "83.059006"}
{"text": "Dilutions of virus and serum were performed in 199 medium containing 2.5 % 1 M HEPES .A positive monkey serum sample with YF antibody content calibrated by a WHO International Reference Preparation was included in each set of test .", "label": "", "metadata": {}, "score": "83.18016"}
{"text": "The apparent \" seroconversion \" in the placebo group may be including genuine fluctuations in the level of previously existing antibodies and variability of laboratory methods .", "label": "", "metadata": {}, "score": "83.311874"}
{"text": "They also compare the observed versus the predicted correlation between H 2 / HI and pressure P .This is plotted versus the observed pressure from Blitz & Rosolowski ( 2006 ) and Leroy et al .", "label": "", "metadata": {}, "score": "83.35786"}
{"text": "The results indicated that the vaccines prepared with WHO-17D substrain and the Brazilian 17DD substrain induced satisfactory immunological response .High seroconversion rates and GMT in international units were comparable to those reported in other randomized trials , 12,15 and in observational studies in adults , in which neutralization tests were used to assess immunological response and the 17D strain vaccine was used .", "label": "", "metadata": {}, "score": "83.638535"}
{"text": "The FDA Guidance suggests a preference for so - called ' random - effects models ' in meta - analyses that will be used to establish the margin in non - inferiority trials .", "label": "", "metadata": {}, "score": "83.67177"}
{"text": "Seroconversion was defined as 4-fold rise in antibody level ( Post - Dose 3/Pre - Dose 1 or Post - Dose 4/Pre - Dose 1 ) .", "label": "", "metadata": {}, "score": "83.81461"}
{"text": "v. 1 .p. 1367- 72 .[Links ] .Bonnel PH .International regulation of yellow fever vaccination .In : Smithburn KC , DurieuxC , Koerber R , Penna HA , Dick GWA , Courtois G et al .", "label": "", "metadata": {}, "score": "84.00274"}
{"text": "Assuming that the proportions in the new treatment and the active control are equal , the total sample size required would be approximately 2,100 per group .", "label": "", "metadata": {}, "score": "84.028694"}
{"text": "In other settings , if the benefits of the new product , in terms of adverse events , ease of administration , and cost are very great , investigators might be willing to forego an even higher percentage of M 1 .", "label": "", "metadata": {}, "score": "84.10546"}
{"text": "Hence , a comparison of a new drug with drug C may not be fair , because drug C may in fact be less effective than drug A and , if the margins were too big , even less effective than placebo .", "label": "", "metadata": {}, "score": "84.366066"}
{"text": "See Rothmann et al .We amplify these concepts below in the section on technical issues .Regulatory perspectives .In March 2010 , the Centers for Drug Evaluation and Research ( CDER ) and Biologics Evaluation and Research ( CBER ) of the US FDA issued a draft Guidance for Industry on non - inferiority trials [ 6 ] .", "label": "", "metadata": {}, "score": "84.4768"}
{"text": "Analyzed sera were from subsets of the Per Protocol Immunogenicity populations in each study .Data on anti - PT levels using an adequately specific assay were not available .", "label": "", "metadata": {}, "score": "84.857445"}
{"text": "Antibody titers were measured pre-and 1 month after the third vaccination ; non - inferiority analyses were performed for seroprotection / seroconversion ( SP / SC ) rates .", "label": "", "metadata": {}, "score": "84.92944"}
{"text": "FHA and anti - FIM , the non - inferiority criteria were met for seroconversion rates , and for anti - FHA , anti - PRN , and anti - FIM , the non - inferiority criteria were met for GMCs , following Dose 4 of Pentacel vaccine relative to Dose 3 of DAPTACEL vaccine .", "label": "", "metadata": {}, "score": "84.952896"}
{"text": "Also important are the phase balance between HI and H 2 , giant molecular cloud ( GMC ) destruction , stellar feedback , and other processes .", "label": "", "metadata": {}, "score": "84.998795"}
{"text": "Analysis of the complete cohort indicated that 90 % of seroconversion among vaccinated subjects were attributable to the vaccines .Excluding the seropositive before vaccination , study vaccines explained more than 93 % of seroconversion of vaccinated subjects .", "label": "", "metadata": {}, "score": "85.092285"}
{"text": "- 50 .[Links ] .Blackwelder WC .Equivalence trials .In : Armitage P , Colton T , editors .Encyclopedia of statistics .", "label": "", "metadata": {}, "score": "85.18468"}
{"text": "That is the case of three studies involving the 17DD substrain .A substantial proportion of participants in the present study showed pre - vaccination seropositivity probably as a result of previous vaccination , which they ignored or concealed .", "label": "", "metadata": {}, "score": "85.561386"}
{"text": "Considerando o grupo placebo , as vacinas explicaram 93 % da soroconvers\u00e3o .Viremia foi detectada entre os dias tr\u00eas e sete em 2,7 % dos participantes vacinados .", "label": "", "metadata": {}, "score": "85.86675"}
{"text": "PCV13+DTaP was as immunogenic as PCV7 for the 7 common pneumococcal antigens , and elicited significantly higher responses to the 6 additional antigens . DTaP responses were comparable across groups .", "label": "", "metadata": {}, "score": "86.114105"}
{"text": "Contrasting the pool of vaccines with placebo controls , the proportion of seroconversion attributable to immunization was 79 % among those with pre - vaccination seropositivity .", "label": "", "metadata": {}, "score": "86.29619"}
{"text": "Both methods weight studies according to their sample size , not the size of the treatment effect within the study .In other words , large studies have a large influence on the pooled effect size , while small studies have a small influence on the estimated effect .", "label": "", "metadata": {}, "score": "86.361946"}
{"text": "DerSimonian R , Laird N : Meta - analysis in clinical trials .Control Clin Trials 1986 , 7 : 177 - 188 .PubMed View Article .", "label": "", "metadata": {}, "score": "86.87762"}
{"text": "Chen et al . also found that the areal rate of star formation was much lower in the long molecular ridge south of 30 Doradus than in the GMCs .", "label": "", "metadata": {}, "score": "87.09665"}
{"text": "From a regulatory perspective , however , both populations are of interest .The US and European regulators are interested in success on both the ITT and the PP populations .", "label": "", "metadata": {}, "score": "87.10507"}
{"text": "Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "87.19423"}
{"text": "p. 815 - 79 .[Links ] .Niedrig M , Lademann M , Emmerich P , Lafrenz M. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays : neutralization test , haemagglutination inhibition test , immunofluorescence assay and ELISA .", "label": "", "metadata": {}, "score": "87.25515"}
{"text": "Statisticians refer to this type of testing as ' closed testing ' , and such a process ensures that the overall experiment - wise error rate is maintained at the correct level when testing more than one hypothesis .", "label": "", "metadata": {}, "score": "87.423065"}
{"text": "Do n't put words in the speaker 's mouth or speculate why something was said - stick to what was said .If you did n't like a speech then say why based on objective rational reasons - not talking points from the other party .", "label": "", "metadata": {}, "score": "87.436"}
{"text": "Suppose that the trial is ' successful , ' that is , drug B is shown to be non - inferior to drug A with respect to the cure rate .", "label": "", "metadata": {}, "score": "87.45525"}
{"text": "Then suppose the next company applies for approval of another drug ( drug C ) using a non - inferiority comparison against drug B. If drug A were actually not superior to placebo in the first trial , it could be fairly easy to show that each new drug is non - inferior to the active control , even when none is any better than placebo .", "label": "", "metadata": {}, "score": "87.68968"}
{"text": "The outcome measures in the previous trials may differ from the outcome in the trial being designed .The intervention in the previous trials might have used different doses from that being contemplated in the new trial , or the relevant trials might have used a drug from the same class as the planned control , but not the same drug .", "label": "", "metadata": {}, "score": "87.83396"}
{"text": "M 2 is often selected to preserve half of the effect of M 1 ; however , when a drug is highly effective , losing half its effect , even though it may still be better than placebo , may not be clinically acceptable ( Figure 4 ) .", "label": "", "metadata": {}, "score": "88.00903"}
{"text": "With seroconversion defined as fourfold increase in pre - vaccination titters , the rates would have been 96.6 % , 98.4 % , 98.5 % and 2.1 % for vaccines produced from 17DD-013Z , 17DD-102/84 , 17D-213/77 seed lots and placebo , respectively .", "label": "", "metadata": {}, "score": "88.06892"}
{"text": "Gender differences in vaccine immunogenicity found in other studies 15 were not confirmed in the present study .Differences in proportion of seroconversion seemed to favor individuals less than 30 years old , but the magnitude of immune response did not confirm the advantage .", "label": "", "metadata": {}, "score": "88.3878"}
{"text": "4 YF vaccines are now considered safe and highly immunogenic .16,25 Protective antibodies induced by the vaccine are experimentally correlated to infection resistance , and have long duration , possibly life long .", "label": "", "metadata": {}, "score": "88.598404"}
{"text": "The investigator must now ask how much of that benefit is acceptable to lose if the new therapy is adopted .The past experience of the investigators may allow them to define the magnitude of a loss of efficacy that they would be clinically willing to accept .", "label": "", "metadata": {}, "score": "88.60576"}
{"text": "This Guidance opens with an introductory overview of non - inferiority trials .It then provides a careful discussion of statistical issues , including methods for determining an appropriate non - inferiority margin , and closes by addressing questions through illustrative examples from recent submissions .", "label": "", "metadata": {}, "score": "88.84774"}
{"text": "In selecting M 2 , investigators and drug developers should consider consulting with patients to ascertain whether a margin acceptable to regulators is too large to be acceptable to patients .", "label": "", "metadata": {}, "score": "88.86459"}
{"text": "Yusuf S , Collins R , et al .: Why do we need some large , simple randomized trials ?Stat Med 1984 , 3 : 409 - 420 .", "label": "", "metadata": {}, "score": "88.92386"}
{"text": "10 Seropositivity has been generally considered to indicate protection against natural infection , although direct evidence is lacking in human beings .Serological correlates of protection against YF are based on data from non - human primates .", "label": "", "metadata": {}, "score": "89.11037"}
{"text": "[Links ] .Poland JD , Calisher CH , Monath TP , Downs WG , Murphy K. Persistence of neutralizing antibody 30 - 35 years after immunization with 17D yellow fever vaccine .", "label": "", "metadata": {}, "score": "89.237785"}
{"text": "As an example , suppose the margin -\u0394 is -3 , and the observed 95 % CI at the end of the trial is [ -2.7 , 1.5].", "label": "", "metadata": {}, "score": "89.334335"}
{"text": "PubMed .Ellenberg SS , Temple R : Placebo - controlled trials and active - control trials in the evaluation of new treatments ; Part 2 : Practical issues and specific cases .", "label": "", "metadata": {}, "score": "89.405914"}
{"text": "Competing interests .The authors declare that they have no competing interests .Authors ' contributions .JS and JW drafted the manuscript .Both authors read and approved the final manuscript .", "label": "", "metadata": {}, "score": "89.54823"}
{"text": "Bigiel et al .( 2010a ) found that outer disk star formation seen by GALEX follows the HI very well in M83 , with a uniform consumption time of 100 Gyr per atom beyond 1.5 R 25 .", "label": "", "metadata": {}, "score": "89.63708"}
{"text": "DISCUSSION .YF vaccines have been shown to induce long - lasting protection .Notwithstanding , the immunogenicity of the YF vaccine has been questioned in recent publications .", "label": "", "metadata": {}, "score": "89.70972"}
{"text": "View Article .Mantel N , Haenszel W : Statistical aspects of the analysis of data from retrospective studies of disease .J Natl Cancer Inst 1959 , 22 : 719 - 748 .", "label": "", "metadata": {}, "score": "89.719604"}
{"text": "To determine the molecular fraction , f H2 , they considered heating and cooling , a radiation field proportional to the SFR , the Sternberg , et al .", "label": "", "metadata": {}, "score": "89.740875"}
{"text": "Interacting galaxies had slightly higher R mol for a given P , but among interacting galaxies , the correlation was still present .A large study of HI , CO , and star formation rates from GALEX ultraviolet and Spitzer 24 \u00b5 observations was made by Bigiel et al .", "label": "", "metadata": {}, "score": "89.8079"}
{"text": "The pertussis immune responses ( GMCs and seroconversion rates ) one month following the third and fourth doses were compared between the two vaccine groups ( Table 5 ) .", "label": "", "metadata": {}, "score": "89.86861"}
{"text": "As an example of how to read the table , consider the row in bold font , in which the true proportion in the active control is 50 % .", "label": "", "metadata": {}, "score": "90.05287"}
{"text": "[Links ] .Lopes OS , Guimaraes SS , Carvalho R. Studies on yellow fever vaccine .III - Dose response in volunteers .J Biol Stand 1988;16:77 - 82 .", "label": "", "metadata": {}, "score": "90.22713"}
{"text": "A detailed account of the vaccine reactogenicity is reported elsewhere .The proportion seropositive after vaccination was above 97 % in the complete cohort as well as in the subset seronegative before vaccination .", "label": "", "metadata": {}, "score": "90.31583"}
{"text": "A serum diphtheria antitoxin level of 0.01 IU / mL is the lowest level giving some degree of protection .Antitoxin levels of at least 0.1 IU / mL are generally regarded as protective . 13 Levels of 1.0 IU / mL have been associated with long - term protection .", "label": "", "metadata": {}, "score": "90.473274"}
{"text": "1998 ) .It might be that magnetic fields and viscosity destabilize outer disks , as discussed in Section 1.1 , but in any case , outer disks appear to be much more stable than inner disks .", "label": "", "metadata": {}, "score": "90.51604"}
{"text": "The document warns , however , that the margin selected must be sufficiently small to ensure that the experimental therapy is better than placebo .In the words of the EMA , ' a minimal requirement for the decision making process involved in interpreting data from a non - inferiority trial is that we must be confident that the test product would have been shown to be efficacious if a placebo - controlled trial had been performed ' .", "label": "", "metadata": {}, "score": "90.775604"}
{"text": "Multilocus sequence typing was also carried out on these strains .Coverage by PCV7 decreased from 71.8 % in 2006 to 51.6 % in 2011 .", "label": "", "metadata": {}, "score": "90.78488"}
{"text": "The Guidance lays out two possible approaches , which we have briefly introduced above : the fixed - margin method ( also known as the double CI method or the 95 - 95 method [ 7 , 8 ] ) and the synthesis method .", "label": "", "metadata": {}, "score": "90.9781"}
{"text": "Data on reactogenicity will be the subject of another publication .METHODS .The intent was to demonstrate that the vaccine from the new seed - lot of the 17DD substrain was at least as immunogenic as the vaccine from the working seed - lot of the 17DD substrain and a vaccine from the WHO-17D seed - lot .", "label": "", "metadata": {}, "score": "91.03383"}
{"text": "( 2008 ) and Leroy et al .( 2008 ) .A key point in their model is that molecular cloud pressures are constant in normal galaxy disks because they are set by HII region pressures ( feedback ) and not the galactic environment .", "label": "", "metadata": {}, "score": "91.15928"}
{"text": "The synthesis method , by contrast , does not require specification of a specific margin or active control effect [ 6 , 9 ] .This approach specifies a threshold for the desired fraction of the effect of the active control that is retained by the new treatment .", "label": "", "metadata": {}, "score": "91.3383"}
{"text": "Safety was assessed using parental reports .Before the booster dose , the SP rates ranged from 65.7 % to 100 % .At least 95.7 % of participants had fourfold post - booster increases in anti - pertussis antibody titres .", "label": "", "metadata": {}, "score": "91.466034"}
{"text": "A meta - analysis comparing treatment A with treatment B starts with T randomized trials .The outcome of the Mantel - Haenszel ( MH ) method is the pooled odds ratio across the T trials .", "label": "", "metadata": {}, "score": "91.515274"}
{"text": "They think the human and robot should hook up .They also complain when John and Cameron are n't in the scene .One fan even asked when they would be kissing .", "label": "", "metadata": {}, "score": "91.54402"}
{"text": "[Links ] .Stefano I , Sato HK , Pannutti CS , Omoto TM , Mann G , Freire MS et al .Recent immunization against measles does not interfere with the efficacy of yellow fever vaccine .", "label": "", "metadata": {}, "score": "91.546646"}
{"text": "For the synthesis and 95 - 95 methods , ' all relevant information ' comprises the set of data addressing the magnitude of the effect of the control treatment compared with placebo .", "label": "", "metadata": {}, "score": "91.57987"}
{"text": "2008 ) shows an example of how much better the SFR scales with CO than either HI or the total gas .The CO and SFR maps of NGC 6946 resemble each other closely , and neither resembles the HI map .", "label": "", "metadata": {}, "score": "91.65919"}
{"text": "The FDA Guidance suggests applying meta - analytic techniques to calculate the estimated effect size and therefore the lower limit of the CI .For convenience in exposition , we discuss here binary outcomes ; much of the discussion is relevant to other types of outcomes as well .", "label": "", "metadata": {}, "score": "91.73054"}
{"text": "Abstract .MADHI , Shabir Ahmed et al .SAMJ , S. Afr . med .j. [ online].2011 , vol.101 , n.12 , pp .", "label": "", "metadata": {}, "score": "91.80811"}
{"text": "The GMT for vaccines did not differ substantially across those age groups , though ( 17.6 , 18.0 and 17.7 IU / ml , respectively ) .", "label": "", "metadata": {}, "score": "91.81502"}
{"text": "Again , call it \u0394. At the end of the trial , a CI is computed around the difference between two test statistics ( equivalence trials typically use 90 % CIs ) and if the CI lies strictly within [ -\u0394 , + \u0394 ] the two treatments are called ' equivalent . '", "label": "", "metadata": {}, "score": "91.93715"}
{"text": "They do this also as a function of metallicity .After considering a galactic cloud population , Krumholz et al .( 2009a ) derive HI versus total gas for different metallicities , and compare this with observations of galaxies having those metallicities .", "label": "", "metadata": {}, "score": "92.35855"}
{"text": "If the outcome is a time - to - event variable or a continuous variable , the meta - analysis is typically performed on the estimated hazard ratios or means , respectively .", "label": "", "metadata": {}, "score": "92.37478"}
{"text": "In the present study , a more stringent definition of seroconversion ( fourfold increase in pre - vaccination titters ) had little impact on the observed rates and differences between vaccines .", "label": "", "metadata": {}, "score": "92.50537"}
{"text": "I admit that in some rare cases I can lose rationality when trying to be a fan of whatever I am a fan of .Be it football , a film , TV show , or music , I can sometimes seem stupid .", "label": "", "metadata": {}, "score": "92.7479"}
{"text": "The clouds are virialized and at uniform pressure until the galactic gas exceeds the column density of a single GMC ; then the pressure equals the galactic pressure .", "label": "", "metadata": {}, "score": "93.06442"}
{"text": "Having selected M 1 ( from the first 95 % ) and M 2 ( from judgment ) , the trial begins .At the end of the trial a 95 % CI is calculated from the observed data .", "label": "", "metadata": {}, "score": "93.07446"}
{"text": "Murante et al .( 2010 ) have a multi - phase SPH code that assumes pressure determines the molecular abundance , and the molecules give the SFR .", "label": "", "metadata": {}, "score": "93.13094"}
{"text": "The mean and the median antibody titters were similar for the vaccines ( Table 2 ) .More than 90 % of those who received one of the vaccines , including the seropositive in the pre - vaccination test , showed at least a two - fold increase in their antibody levels ( Table 2 ) .", "label": "", "metadata": {}, "score": "93.183754"}
{"text": "A simple microculture method for the study of group B arboviruses .Bull World Health Organ 1969;40:113 - 21 .[Links ] . dos Santos CN , Post PR , Carvalho R , Ferreira II , Rice CM , Galler R. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213 .", "label": "", "metadata": {}, "score": "93.43225"}
{"text": "What is usually called ' biocreep ' is more precisely ' virtual biocreep , ' where each successive product may be a little bit less effective than the previous product [ 17 , 18 ] .", "label": "", "metadata": {}, "score": "93.44237"}
{"text": "You use your chosen Type I error rate or \u03b1 , your desired power , and \u03b3 to select your sample size .The goal of your experiment is to reject that null hypothesis , thus \u03b3 is in some sense a tool to help you select your sample size .", "label": "", "metadata": {}, "score": "93.47847"}
{"text": "Virology 2001;290:309 - 19 .[Links ] .Guerra HL , Sardinha TM , da Rosa PAT , Costa MFL .Efetividade da vacina antiamar\u00edlica17D : uma avalia\u00e7\u00e3o epidemiol\u00f3gica em servi\u00e7os e sa\u00fade .", "label": "", "metadata": {}, "score": "93.60117"}
{"text": "[Links ] .Lang J , Zuckerman J , Clarke P , Barret P , Kirkpatrick C , Blondeau C. Comparison of the immunogenicity and safery fo two 17D yellow fever vaccines .", "label": "", "metadata": {}, "score": "93.66481"}
{"text": "SP / SC rates for the DTaP - IPV//PRP - T vaccine were high and non - inferior to the controls .Reactogenicity was low for each group and no hypotonic hyporesponsive episode or seizure was reported .", "label": "", "metadata": {}, "score": "93.8275"}
{"text": "Links ] .Roche JC , Jouan A , Brisou B , Rodhain R , Fritzell B , Hannoun C. Comparative clinical study of a new 17D thermostable yellow fever vaccine .", "label": "", "metadata": {}, "score": "93.88553"}
{"text": "Eligibility criteria were age 18 years or more , no previous vaccination against YF , no plans to travel to YF endemic areas during the study period , availability for study follow - up , and signed an informed consent .", "label": "", "metadata": {}, "score": "93.89016"}
{"text": "Kayhty H , et al .The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983 ; 147:1100 .", "label": "", "metadata": {}, "score": "93.973145"}
{"text": "Locally there can be islands of high column density where Q is small enough to be in the unstable region ( van Zee et al .", "label": "", "metadata": {}, "score": "94.2998"}
{"text": "The total time from DNA extraction from CSF to PCR analysis was 1.5 hour .The detection rate of pathogens with PCR was significantly better than that with cultures in patients with antibiotic administration .", "label": "", "metadata": {}, "score": "94.436325"}
{"text": "Data on anti - PT responses obtained from an adequately specific assay were available on only a non - random subset of study participants .The subset of study participants was representative of all study participants with regard to Pre - Dose 1 , Post - Dose 3 and Post - Dose 4 GMCs of antibodies to FHA , PRN and FIM .", "label": "", "metadata": {}, "score": "94.55854"}
{"text": "Table 6 : Anti - PRP Seroprotection Rates and GMCs One Month Following Three Doses of Pentacel Vaccine or Separate DTaP + IPV + ActHIB Vaccines Administered at 2 , 4 , and 6 Months of Age in Studies 494 - 01 , P3T06 , and M5A10 .", "label": "", "metadata": {}, "score": "94.691315"}
{"text": "J ohn Amato points out on Crooks and Liars that since the election , the Sunday talk shows have returned to the usual conservative bias : .", "label": "", "metadata": {}, "score": "94.72928"}
{"text": "A new oral vaccine that only prevents 48 % of disease would still be much more effective than placebo , but would hardly be attractive , even if less painful to the child than a shot .", "label": "", "metadata": {}, "score": "94.75998"}
{"text": "Bigiel et al .( 2010b ) studied SF rates in the far - outer disks of 17 spiral and 5 dwarf galaxies , where the gas is highly HI dominated .", "label": "", "metadata": {}, "score": "94.81247"}
{"text": "Participants in the placebo group were vaccinated against YF after the scheduled opening of the codes .The research protocol was approved by Research Ethics Committees from Funda\u00e7\u00e3o Oswaldo Cruz and from the Brazilian Army .", "label": "", "metadata": {}, "score": "94.856255"}
{"text": "The Guidance states : . 'It can also show that the test drug had an effect greater than some fraction of the control drug effect , depending on the M2 that is used . '", "label": "", "metadata": {}, "score": "94.88294"}
{"text": "[Links ] .Monath TP , Nichols R , Archambault WT , Moore L , Marchesani R , Tian J et al .Comparative safety and immunogenicity of two yellow fever 17D vaccines ( Arilvax and IF - Vax ) in a Phase III Multicenter , double - blind clinical trial .", "label": "", "metadata": {}, "score": "95.01131"}
{"text": "They showed seroconversion rates of 67 % , 76 % , 77 % and 16 % in the groups that received the vaccines produced from 17DD-013Z , 17DD-102/84 , 17D-213/77 seed - lots and the placebo , respectively .", "label": "", "metadata": {}, "score": "95.04328"}
{"text": "We advocate considering whether to revise the relevant legislation to modify the regulations so that regulators are legally able to take into account multiple dimensions of a new product .", "label": "", "metadata": {}, "score": "95.072105"}
{"text": "Oxford : Oxford University Press , 306 pp ; 2000 .Teo KK , Yusuf S , et al .: Effects of intravenous magnesium in suspected acute myocardial infarction : overview of randomized trials .", "label": "", "metadata": {}, "score": "95.262955"}
{"text": "YF vaccines recommended by the World Health Organization ( WHO ) are from 17D and 17DD substrains , which have minor differences in nucleotide sequences .", "label": "", "metadata": {}, "score": "95.56268"}
{"text": "p. 741 - 79 .[Links ] .Galler R , Pugachev KV , Santos CLS , Ocran SW , Jabor AV , Rodrigues SG et al .", "label": "", "metadata": {}, "score": "95.580284"}
{"text": "Whether the lower anti - PRN GMC following Dose 4 of Pentacel vaccine relative to Dose 4 of DAPTACEL vaccine in US children correlates with diminished efficacy of Pentacel vaccine against pertussis is unknown .", "label": "", "metadata": {}, "score": "95.71628"}
{"text": "The typical presentation of a meta - analysis shows a forest plot depicting the results of each trial , and then a summary statistic showing the estimated effect .", "label": "", "metadata": {}, "score": "95.77968"}
{"text": "As the working seed lot was used up a new seed lot was prepared and tested , confirming the genetic stability of the virus , its safety in the monkey neurovirulence test ( unpublished data ) , and freedom from avian leucosis infectious virus .", "label": "", "metadata": {}, "score": "95.91206"}
{"text": "The standard method , introduced by DerSimonian and Laird [ 14 ] , assumes that the effect size ( which in the case of binomial variables is the log odds ratio ) comes from a normal distribution with mean \u03bc and variance \u03c3 2 .", "label": "", "metadata": {}, "score": "95.9666"}
{"text": "15 Generalization of the results to age groups not included in this study , particularly children below two years of age , are not warranted considering the potential interference of maternal immunity and concomitant administration of other vaccines .", "label": "", "metadata": {}, "score": "96.00766"}
{"text": "[Links ] .Monath TP .Yellow fever .In : Plotkin SA , Orenstein WA , editors .Vaccines .3 rd ed .", "label": "", "metadata": {}, "score": "96.16994"}
{"text": "Two more formal approaches to the margin and analysis are the putative placebo ( also known as synthesis method ) and the 95 - 95 approach in Rothmann [ 7 , 8 ] .", "label": "", "metadata": {}, "score": "96.189705"}
{"text": "Instead , the EMA directs trial sponsors to use a combination of statistical and clinical judgment .The method of selecting a margin could come from a Delphi - type approach asking experts how much benefit over placebo they are willing to forego by using the new product instead of the product already shown to be effective .", "label": "", "metadata": {}, "score": "96.21509"}
{"text": "From the comparisons between each vaccine and the placebo it was derived proportions of seroconversion attributable to the vaccine , with 95 % CI . 2 Antibody titters from vaccines and placebo were compared in reverse cumulative distribution plots .", "label": "", "metadata": {}, "score": "96.26171"}
{"text": "[Links ] .Wolga J , Rodhain F , Hannoun C , Dodin A , Fritzell B , Loucq C , Stahl JP et al .", "label": "", "metadata": {}, "score": "96.4487"}
{"text": "That is , over time , organisms develop resistance to earlier drugs in the pharmacopoeia , meaning that each new drug is being compared with an active control that might be becoming less and less effective against a strengthening infectious agent .", "label": "", "metadata": {}, "score": "96.581894"}
{"text": "The US regulators [ 6 ] cite ' significant concerns with the possibility of informative censoring ' in an ' as - treated ' or PP , analysis , and advise investigators to plan both types of analyses in their non - inferiority trials .", "label": "", "metadata": {}, "score": "96.63714"}
{"text": "You then choose an alternative hypothesis stating that the difference between the means , or some other statistic , is \u03b3 .Throughout this paper , we assume that larger positive outcomes are better than smaller positive outcomes , and a positive treatment difference , \u03b3 , provides evidence of benefit .", "label": "", "metadata": {}, "score": "96.74297"}
{"text": "We know that molecular cloud pressures in the Milky Way are about constant from the Larson ( 1981 ) laws , which require this for virialized clouds , but we do n't really know the reason for it .", "label": "", "metadata": {}, "score": "97.02453"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT :The 7-valent pneumococcal conjugate vaccine ( PCV7 ) and Haemophilus influenzae type b ( Hib ) vaccine reduce nasopharyngeal carriage of vaccine - type bacteria , which may in turn influence the presence of other nasopharyngeal bacterial pathogens .", "label": "", "metadata": {}, "score": "97.11245"}
{"text": "J Biol Stand 1986;14:289 - 95 .[Links ] .World Health Organization .Global programme for vaccines and immunization / Division of emerging and other communicable diseases suveillance and control .", "label": "", "metadata": {}, "score": "97.20556"}
{"text": "( 2008 ) found unstable islands of star formation in the outer part of M83 .In these regions , the star formation followed a steep KS law from point to point with a slope of about 1.4 ( Dong et al .", "label": "", "metadata": {}, "score": "97.349976"}
{"text": "The first 95 % ( or how does the control compare with placebo ) .As described above , the purpose of the first 95 % in the 95 - 95 method is to calculate the effect size for the control group that gives a reasonable assurance of being no less than the true effect size .", "label": "", "metadata": {}, "score": "97.38061"}
{"text": "ISSN 2078 - 5135 .ABSTRACT OBJECTIVE :To assess the immunogenicity and safety of a pentavalent diphtheria , tetanus , acellular pertussis , inactivated poliovirus , Hib polysaccharide - conjugate vaccine booster .", "label": "", "metadata": {}, "score": "97.5511"}
{"text": "A method of Peto described by Yusuf [ 13 ] is also often used in these settings .The method differs slightly from the MH approach ; however , for large sample sizes , the two methods yield almost identical results .", "label": "", "metadata": {}, "score": "97.558685"}
{"text": "Consider the situation with an existing drug ( drug A ) that is approved for the treatment of an infectious disease on the basis of a placebo - controlled trial .", "label": "", "metadata": {}, "score": "97.571014"}
{"text": "Armitage P , Berry G. Statistical methods in medical research .3 rd ed .Oxford : Blackwell Science ; 1994 .[Links ] .", "label": "", "metadata": {}, "score": "97.80177"}
{"text": "There are some who want more talking and less action .There are some fans who complain about logical holes in the plot - like how did one of the Terminators make it through the time displacement without being covered with living tissue .", "label": "", "metadata": {}, "score": "97.8407"}
{"text": "As PRNT is considered highly specific , previous infections by other flaviruses were not expected to cause false - positive results .17 There were no striking imbalances in the distribution of pre - vaccination seropositivity across vaccination and placebo groups that could affect their comparability .", "label": "", "metadata": {}, "score": "97.85896"}
{"text": "Viremia was detected in 2.7 % of vaccinated subjects from Day 3 to Day 7 .CONCLUSIONS : The equivalent immunogenicity of yellow fever vaccines from the 17D and 17DD substrains was demonstrated for the first time in placebo - controlled double - blind randomized trial .", "label": "", "metadata": {}, "score": "97.9948"}
{"text": "[Links ] .Reed GF , Meade BD , Steinhoff MC .The reverse cumulative distribution plot : a graphic method of exploratory analysis of antibody data .", "label": "", "metadata": {}, "score": "98.22795"}
{"text": "Leroy et al . also found that dwarf galaxies are forming stars at their average historical rate , whereas spirals are forming stars at about half of their average rate .", "label": "", "metadata": {}, "score": "98.457275"}
{"text": "We KNOW what the GOP thinks , we do n't need to see them on the air repeating the talking points , in fact we do n't need YOU repeating the GOP talking points .", "label": "", "metadata": {}, "score": "98.565796"}
{"text": "Viremia was detected in only 2.7 % of vaccinated subjects ( 2.2 % of those who received 17DD and 3.7 % with 17D ) , from Day 3 to Day 7 after vaccination .", "label": "", "metadata": {}, "score": "98.727806"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .", "label": "", "metadata": {}, "score": "98.76542"}
{"text": "If so , a drug shown to be effective in the past would perhaps not be shown to be effective were the same trial performed today .", "label": "", "metadata": {}, "score": "98.9481"}
{"text": "In many cases , such a trial is not ethically acceptable .That is , randomizing participants to placebo may not be appropriate when an existing therapy with a proven survival benefit exists ( for example , in cancer ) , whereas in other cases ( for example , pain relief ) a three - arm trial could work well .", "label": "", "metadata": {}, "score": "99.1227"}
{"text": "O estudo completou o processo de valida\u00e7\u00e3o cl\u00ednica do novo lote - semente de vacina , al\u00e9m de ampliar as bases para utiliza\u00e7\u00e3o da vacina brasileira em outros pa\u00edses e de trazer alternativas de subcepas para o produtor da vacina no Brasil .", "label": "", "metadata": {}, "score": "99.32753"}
{"text": "The pressure at the bottom of the shielding layer , which is the molecular cloud surface pressure , scales directly with the column density of the shielding layer .", "label": "", "metadata": {}, "score": "99.39641"}
{"text": "The mean antibody titter at the 50 % endpoint of the standard serum was then calculated and added to the log 10 endpoint for each sample to give log 10 mIU / ml .", "label": "", "metadata": {}, "score": "99.63559"}
{"text": "ACKNOWLEDGEMENTS .COLLABORATIVE GROUP FOR THE STUDY OF YELLOW FEVER VACCINES .DISCLOSURE .Four of the authors were employed by the vaccine manufacturer ( Bio - Manguinhos , Funda\u00e7\u00e3o Oswaldo Cruz ) and three others worked in other units of Funda\u00e7\u00e3o Oswaldo Cruz .", "label": "", "metadata": {}, "score": "99.64931"}
{"text": "The speeches are n't for YOU .They are for those spending the week at the convention .If you feel like I do , that the \" commentors \" plain suck , then watch the convention unfiltered and uninterrupted on C - SPAN .", "label": "", "metadata": {}, "score": "100.353325"}
{"text": "There are 340 medical institutions that actively participated in our surveillance project throughout Japan .We collected 252 strains from patients with IPD in 2006 ( pre - PCV7 ) , 280 strains in 2010 ( under 10 % immunization achieved ) , and 128 strains in 2011 ( 50 % to 60 % immunization ) .", "label": "", "metadata": {}, "score": "100.43542"}
{"text": "16 Their implications for safety will be analysed in another paper .In conclusion , the vaccine produced from a new seed - lot generated from a single passage of the 17DD-102/84 seed - lot showed high immunogenicity , and could replace the original seed - lot for the production of the YF vaccine .", "label": "", "metadata": {}, "score": "100.453835"}
{"text": "This morphology is in agreement with GALEX observations ( Thilker et al .2005 , Gil de Paz et al .2005 ) .Outer disks can be Toomre - stable on average because the gas and star column densities are very low .", "label": "", "metadata": {}, "score": "100.79474"}
{"text": "Per Protocol Immunogenicity population for anti - FHA , anti - PRN , and anti - FIM .Non - random subset of per Protocol Immunogenicity population for anti - PT .", "label": "", "metadata": {}, "score": "100.85347"}
{"text": "Outer disk arms could be spiral waves radiating from the inner disk ( Bertin & Amorisco 2010 ) .Boissier et al .( 2008 ) observed the galaxy - integrated KS law in low surface brightness galaxies , using a SFR from GALEX NUV observations .", "label": "", "metadata": {}, "score": "100.87942"}
{"text": "IPV indicates Poliovirus Vaccine Inactivated .\u00a7 Non - inferiority criterion not pre - specified .Concomitantly Administered Vaccines .The immune responses to hepatitis B vaccine and PCV7 were evaluated one month following the third dose .", "label": "", "metadata": {}, "score": "101.199066"}
{"text": "Links ] .Minist\u00e9rio da Sa\u00fade .Funda\u00e7\u00e3o Nacional de Sa\u00fade .Programa Nacional de Imuniza\u00e7\u00f5es .Manual de procedimentos para vacina\u00e7\u00e3o .3 \u00aa ed .", "label": "", "metadata": {}, "score": "101.39478"}
{"text": "PRNT was conducted in serial two - fold dilutions starting at 1:5 , in 50 \u00b5l of inactivated serum in 96 well tissue culture plates .", "label": "", "metadata": {}, "score": "101.57921"}
{"text": "( 2009b ) suggest , or it could be the weight of the HI shielding layer , which has a regulatory effect on pressure ( Elmegreen 1989 ) .", "label": "", "metadata": {}, "score": "101.819824"}
{"text": "23,25 In Brazil the number of reported YF cases has been increasing in the last ten years peaking in 2000 ( 85 cases ) , and approaching more densely populated areas in the Southeast .", "label": "", "metadata": {}, "score": "101.834946"}
{"text": "I think we were too expensive and DOLLHOUSE was a lot cheaper , \" Dekker revealed his theory .Admin Links .Our Sponsors .Links relacionados .", "label": "", "metadata": {}, "score": "101.90788"}
{"text": "I Escola Nacional de Sa\u00fade P\u00fablica .Funda\u00e7\u00e3o Oswaldo Cruz ( Fiocruz ) .Rio de Janeiro , RJ , Brasil II Instituto de Tecnologia em Imunogiol\u00f3gicos .", "label": "", "metadata": {}, "score": "102.04225"}
{"text": "The proportions of participants achieving diphtheria antitoxin seroprotective levels one month following three and four doses of Pentacel vaccine or DAPTACEL vaccine in Study P3T06 are provided in Table 3 .", "label": "", "metadata": {}, "score": "102.09784"}
{"text": "Show the speech without comments .After the speech , talk about the points made - are they based in reality - are they truthful .", "label": "", "metadata": {}, "score": "102.37105"}
{"text": "Classical statistics is non - intuitive enough when you are trying to show that a new intervention is better than a previous one .You can not prove what you want to prove ; all you can say is that the data you observe provide sufficient evidence to reject the hypothesis that the two interventions have the same effect .", "label": "", "metadata": {}, "score": "102.44832"}
{"text": "Our data identified an unexpected pattern of pneumococcal serotype replacement following PCV7 .Continuous monitoring of pneumococcal carriage is important for decisions regarding the future of national vaccination policy in Japan .", "label": "", "metadata": {}, "score": "102.5083"}
{"text": "There is no obvious Q threshold .Krumholz & Tan ( 2007 ) showed that the conversion rate from gas to stars per unit free fall time is about constant inside clouds over a wide range of densities .", "label": "", "metadata": {}, "score": "102.702995"}
{"text": "Sometimes , investigators do not carry out such a formal analysis ; instead they figure out how much money they can spend .From there , they determine the largest trial that they can run , and justify the margin after the fact .", "label": "", "metadata": {}, "score": "102.72908"}
{"text": "5,17 Serologic analyses were conducted at the Laboratory of Viral Technology at Funda\u00e7\u00e3o Oswaldo Cruz .Venous blood samples were drawn just before , between Days 4 and 20 , and 30 days or more after vaccination .", "label": "", "metadata": {}, "score": "102.913025"}
{"text": "In Study M5A10 , participants were randomized to receive Pentacel vaccine or separately administered DAPTACEL , IPOL , and ActHIB vaccines at 2 , 4 , and months of age .", "label": "", "metadata": {}, "score": "103.128944"}
{"text": "Federal Register 1985;50(240):51002 - 117 .Vitek CR , Wharton M. Diphtheria toxoid .In : Plotkin SA , Orenstein WA , Offit PA , editors .", "label": "", "metadata": {}, "score": "103.45761"}
{"text": "[Links ] .Hussain AI , Johnson JA , Freire MS , Heneine W. Identification and characterization of avian retroviruses in chicken embryo - derived yellow fever vaccines : investigations of transmission to vaccine recipients .", "label": "", "metadata": {}, "score": "103.47609"}
{"text": "( 2010 ) simulated galactic star formation with special attention to the outer disks .The star formation model followed Springel & Hernquist ( 2002 ) with radiative cooling , star formation in the cold phase , no specific molecular phase , and a volume - Schmidt law , SFR total gas 1.5 .", "label": "", "metadata": {}, "score": "103.47962"}
{"text": "Rev. Sa\u00fade P\u00fablica v.38 n.5 S\u00e3o Paulo oct .2004 .ARTIGOS ORIGINAIS .Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines : a randomized trial .", "label": "", "metadata": {}, "score": "103.49966"}
{"text": "14 Briefly , freeze - dried vaccines ( or placebo ) in 50-doses vials were diluted in sterile and apyrogenic saline solution , kept between 2\u00baC and 8\u00baC , protected from light , and discarded after four hours .", "label": "", "metadata": {}, "score": "103.72307"}
{"text": "From January to May 2001 , 1,087 volunteers received vaccine or placebo , donated pre - vaccination blood sample and were interviewed .Six ( 0.6 % ) of them did not return for post - vaccination blood collection for reasons unrelated to adverse events .", "label": "", "metadata": {}, "score": "103.75339"}
{"text": "Fiocruz .Rio de Janeiro , RJ , Brasil III Instituto de Biologia do Ex\u00e9rcito .Rio de Janeiro , RJ , Brasil .OBJECTIVE :", "label": "", "metadata": {}, "score": "103.76252"}
{"text": "[Links ] .Fleiss JL .The design and analysis of clinical experiments .New York : John Wiley & Sons Inc. ; 1986 .", "label": "", "metadata": {}, "score": "103.825066"}
{"text": "As mentioned earlier , this change in effect is termed ' biocreep ' in the case of drugs , and ' technocreep ' in the case of devices .", "label": "", "metadata": {}, "score": "103.86742"}
{"text": "These definitions of M 1 and M 2 come from the notation used in the FDA Guidance document , which we discuss in the next section .", "label": "", "metadata": {}, "score": "103.96101"}
{"text": "The country just rejected Conservatives and the entire GOP and gave Obama a complete mandate , but does that matter to the networks ?Atrios : .", "label": "", "metadata": {}, "score": "104.05806"}
{"text": "( 2008 ) .They considered the local star formation law with a resolution of 750 pc .Bigiel et al .found that SFR CO , and that the timescale for conversion from H 2 to stars was about 2 Gyr .", "label": "", "metadata": {}, "score": "104.109146"}
{"text": "5th ed .Philadelphia , PA : W. B. Saunders ; 2008 .p. 139- 56 .Wassilak SGF , et al .Tetanus toxoid .", "label": "", "metadata": {}, "score": "104.31994"}
{"text": "The star formation law may also be written as a linear relation for molecules , with SFR H2 1 ( e.g. , Rownd & Young 1999 ) .", "label": "", "metadata": {}, "score": "104.482925"}
{"text": "The proportions of participants achieving tetanus antitoxoid seroprotective levels one month following three and four doses of Pentacel vaccine or DAPTACEL vaccine in Study P3T06 are provided in Table 3 .", "label": "", "metadata": {}, "score": "104.8591"}
{"text": "Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria , tetanus , inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2 , 3 , 4 or 3 , 4 , 5 months of age in infants in China .", "label": "", "metadata": {}, "score": "104.92298"}
{"text": "12 Monkeys was one of two pilots most recently ordered by Syfy .The other , Bryan Fuller 's High Moon , is not going forward .", "label": "", "metadata": {}, "score": "105.444885"}
{"text": "Publication date & source : 2011 - 02 - 24 , Vaccine ., 29(10):1913 - 20 .Epub 2011 Jan 8 .Publication type : Comparative Study ; Randomized Controlled Trial ; Research Support , Non - U.S. Gov't .", "label": "", "metadata": {}, "score": "105.446815"}
{"text": "Protection against pertussis by DAPTACEL vaccine was sustained for the 2-year follow - up period .Available stored sera from infants who received DAPTACEL vaccine in the Sweden I Efficacy Trial and sera from children who received PCV7 concomitantly with the first three doses of Pentacel vaccine in Study 494 - 01 ( Table 1 ) were assayed in parallel .", "label": "", "metadata": {}, "score": "105.487686"}
{"text": "12 Monkeys also joins another recently ordered new Syfy series based on a movie , Dominion , adaptation of the feature Legion .They list \" V \" for Natalie Chaidez , but more interesting ( imo ) was her involvement with TTSCC .", "label": "", "metadata": {}, "score": "105.77529"}
{"text": "Polioviruses , of which there are three serotypes ( Types 1 , 2 , and 3 ) are enteroviruses .The presence of poliovirus type - specific neutralizing antibodies has been correlated with protection against poliomyelitis .", "label": "", "metadata": {}, "score": "106.44485"}
{"text": "He had no teeth , and he was slobbering all over himself .I 'm thinking , ' You can have your money back , just get me out of here .", "label": "", "metadata": {}, "score": "106.700836"}
{"text": "Serum levels of liver enzymes aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , gamma - glutamyl transpeptidase ( GGT ) and alkaline phosphatase ( AP ) were measured in all serum samples .", "label": "", "metadata": {}, "score": "107.18651"}
{"text": "In : Armitage P , Colton T , editors .Encyclopedia of statistics .Chichester : John Wiley & Sons ; 1998 .v. 1 .", "label": "", "metadata": {}, "score": "107.240135"}
{"text": "The vaccination schedules of Pentacel vaccine , Control vaccines , and concomitantly administered vaccines used in Studies 494 - 01 , P3T06 , and 494 - 03 are provided in Table 1 . [", "label": "", "metadata": {}, "score": "107.24899"}
{"text": "\" TTSCC \" was officially canceled in mid May following two low - rating seasons while it 's Friday partner in midseason , \" Dollhouse \" , which also experienced the same problem was given another chance .", "label": "", "metadata": {}, "score": "107.34625"}
{"text": "Poliomyelitis .Invasive Disease Due To H influenzae Type b .Anti - PRP seroprotection rates and GMCs one month following Dose 3 of Pentacel vaccine or separately administered ActHIB vaccine in studies 494 - 01 , P3T06 , and M5A10 are presented in Table 6 .", "label": "", "metadata": {}, "score": "107.3893"}
{"text": "\"Well , not a TV movie , but kind of like a direct - to - DVD movie .Obviously it 's difficult because the show is based on a movie and they just had one come out , so it 's kind of hard to make a movie with our show because everyone has kind of forgotten about us .", "label": "", "metadata": {}, "score": "107.398926"}
{"text": "Unlike the star formation rate per molecule , the molecule - to - atom ratio does correlate well with environmental parameters .The molecular fraction is a smooth function of environmental parameters ( e.g. , pressure ) ; no thresholds were seen .", "label": "", "metadata": {}, "score": "108.165726"}
{"text": "Investigation conducted at Funda\u00e7\u00e3o Oswaldo Cruz and Instituto de Biologia do Ex\u00e9rcito , Rio de Janeiro , RJ , Brasil .Oral presentation in the Third World Congress on Vaccines and Immunisation , Opatija Adriatic Riviera , Croatia , June 4 , 2002 .", "label": "", "metadata": {}, "score": "108.39441"}
{"text": "Links ] .Freestone DS .Yellow fever vaccine .In : Plotkin SA , Mortimer EA , editors .Vaccines .2 nd ed .", "label": "", "metadata": {}, "score": "109.44605"}
{"text": "[ Document WHO / EPI / GEN/98.08].[Links ] .Correspondence to Luiz Antonio Bastos Camacho Fiocruz Rua Leopoldo Bulh\u00f5es , 1480 sala 820 Manguinhos 21041 - 210 Rio de Janeiro , RJ , Brasil E - mail : luiz.camacho@ensp.fiocruz.br .", "label": "", "metadata": {}, "score": "109.51053"}
{"text": "The medium was discarded and replaced with 199 medium containing 3.5 % carboxymethyl cellulose in volumes of 100 \u00b5l .After incubation at 37\u00baC in 5 % CO 2 atmosphere for seven days , the monolayers were fixed with formalin , stained with crystal violet and plaques counted at a magnification of x 12.5 on a vertically mounted 35 mm projector with wide angle lens .", "label": "", "metadata": {}, "score": "109.746475"}
{"text": "Pediatr Res 1973;7:103- 10 .Peltola H , et al .Haemophilus influenzae type b capsular polysaccharide vaccine in children : a double - blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland .", "label": "", "metadata": {}, "score": "110.17188"}
{"text": "Clin Infect Dis 2008 , 47 ( Suppl 3 ) : S108-S120 .PubMed View Article .Copyright .\u00a9 Schumi and Wittes ; licensee BioMed Central Ltd. 2011 .", "label": "", "metadata": {}, "score": "110.38023"}
{"text": "Brazil is the only producer and the major consumer of a 17DD substrain YF vaccine , which had never been compared in controlled studies with the 17D substrain and with placebo .", "label": "", "metadata": {}, "score": "110.84044"}
{"text": "This study in Japan compared the safety and immunogenicity of PCV13 with PCV7 .Healthy Japanese infants received PCV13 and diphtheria , tetanus , acellular pertussis vaccine ( DTaP ) , PCV7 and DTaP , or DTaP alone subcutaneously as a 3-dose infant series , with a fourth dose at 12 months of age .", "label": "", "metadata": {}, "score": "110.86618"}
{"text": "[16 ] for a discussion of a random - effects meta - analysis on the use of magnesium , which led to erroneous results .", "label": "", "metadata": {}, "score": "110.96651"}
{"text": "Ensaios controlados aleat\u00f3rios .Yellow fever ( YF ) is an acute viral disease of public health importance in Africa and South America , and of interest for travel clinics in other areas of the world .", "label": "", "metadata": {}, "score": "111.65277"}
{"text": "METHODS : An equivalence trial was carried out involving 1,087 adults in Rio de Janeiro .Vaccines produced by Bio - Manguinhos , Fiocruz ( Rio de Janeiro , Brazil ) were administered following standardized procedures adapted to allow blocked randomized allocation of participants to coded vaccine types ( double - blind ) .", "label": "", "metadata": {}, "score": "111.895035"}
{"text": "I read the producers notes and on occasion read the blog for each episode .Although sometimes the comments from other fans bother me .There are different views of the show and that is okay .", "label": "", "metadata": {}, "score": "112.614044"}
{"text": "The 17DD substrain is produced only in Brazil but is distributed in other Latin American and African countries where 17D vaccines have been utilized .Moreover , the results indicated a choice of vaccine virus for the vaccine manufacturer in Brazil .", "label": "", "metadata": {}, "score": "112.89609"}
{"text": "The agreement is good . where the star formation rate in a free fall time is the fraction of the gas that turns into stars in a free fall time , SFR ff , divided by the free fall time , t ff .", "label": "", "metadata": {}, "score": "113.225204"}
{"text": "Trained nurses adjusted routine immunization procedures to meet the requirements for blinding and randomization .All vaccines were produced by the Institute of Immunobiological Technology in Funda\u00e7\u00e3o Oswaldo Cruz , Rio de Janeiro .", "label": "", "metadata": {}, "score": "113.38394"}
{"text": "eds .Combined vaccines and simultaneous administration .Current issues and perspectives .New York , NY : The New York Academy of Sciences .Robbins JB , et al .", "label": "", "metadata": {}, "score": "113.4126"}
{"text": "Three received other vaccines during the follow - up and one was 15 years old .A large proportion of participants were found to be seropositive in pre - vaccination tests ( Table 1 ) .", "label": "", "metadata": {}, "score": "113.56102"}
{"text": "From 2000 to 2004 , 26,368,050 doses of YF vaccine have been exported to 50 different countries in South and Central America , Africa and Asia .", "label": "", "metadata": {}, "score": "114.00639"}
{"text": "Crown Copyright ( c ) 2011 .Published by Elsevier Ltd.All rights reserved .Indicators .Related links .Share .SAMJ : South African Medical Journal .", "label": "", "metadata": {}, "score": "114.390915"}
{"text": "Thomas Dekker aka John Connor revealed in an interview with TV Addict that it may as well be a direct - to - DVD movie .", "label": "", "metadata": {}, "score": "114.434525"}
{"text": "I was kinda dissapointed that this was n't shown as a special event or as a mini series on FOX , BUT hey beggars ca n't be choosers .", "label": "", "metadata": {}, "score": "114.470474"}
{"text": "These islands have to be larger than the Jeans mass , which might be 10 7 M .Spiral arms and large disturbances in pressure could make unstable regions like this .", "label": "", "metadata": {}, "score": "115.28636"}
{"text": "\" I ca n't tell you how badly I wanted out of there . \"Denver rookie QB John Elway , on Jack Lambert , after Lambert and the Steelers knocked Elway out of his first game as a pro ( 1983 ) .", "label": "", "metadata": {}, "score": "116.03076"}
{"text": "Geneva : World Health Organization ; 1956 .Annex 2 .p. 205 - 8 .[ WHO Monograph Series , 30 ] [ Links ] .", "label": "", "metadata": {}, "score": "116.481476"}
{"text": "In Japan , the heptavalent pneumococcal conjugate vaccine ( PCV7 ) has been introduced on a voluntary basis since February 2010 , and official financial support for children under 5 years started in November 2010 .", "label": "", "metadata": {}, "score": "118.42615"}
{"text": "Pentacel .\" Rubella is usually mild in children .Make sure you and your child are protected from rubella by getting vaccinated on schedule .", "label": "", "metadata": {}, "score": "118.72568"}
{"text": "Tetanus Antitoxoid .Per Protocol Immunogenicity population .Pertussis .In a clinical pertussis vaccine efficacy study conducted in Sweden during 1992 - 1995 ( Sweden I Efficacy Trial ) , 2,587 infants received DAPTACEL vaccine and 2,574 infants received a non - US licensed DT vaccine as placebo at 2 , 4 , and 6 months of age .", "label": "", "metadata": {}, "score": "118.98692"}
{"text": "Vaccines .5th ed .Philadelphia , PA : W.B. Saunders ; 2008 .p. 805 - 39 .Sutter RW , et al .Defining surrogate serologic tests with respect to predicting protective vaccine efficacy : Poliovirus vaccination .", "label": "", "metadata": {}, "score": "119.230644"}
{"text": "But , in case you 've missed the skinny on this one , here are some reviews : .Steve as you well know I 'm a big Breakerhead as well .", "label": "", "metadata": {}, "score": "119.36801"}
{"text": "Categories .Archives by Month .Most who read this blog know that I 'm a big fan of the series Prison Break that ran on FOX .", "label": "", "metadata": {}, "score": "119.43918"}
{"text": "Well , in our country , ' said Alice , still panting a little , ' you 'd generally get to somewhere else - if you ran very fast for a long time as we 've been doing . '", "label": "", "metadata": {}, "score": "120.84627"}
{"text": "REFERENCES .DAPTACEL \u00ae [ full prescribing information].Toronto , ON : Sanofi Pasteur ; 2011 .Department of Health and Human Services , Food and Drug Administration .", "label": "", "metadata": {}, "score": "121.353836"}
{"text": "The efficacy of Pentacel vaccine is based on the immunogenicity of the individual antigens compared to separately administered vaccines .While Pentacel and DAPTACEL vaccines contain the same pertussis antigens , manufactured by the same process , Pentacel vaccine contains twice as much detoxified PT and four times as much FHA as DAPTACEL vaccine .", "label": "", "metadata": {}, "score": "122.03605"}
{"text": "Natalie Chaidez ( V ) serves as showrunner and executive produces alongside Atlas Entertainment 's Charles Roven and Richard Suckle .Jeffrey Reiner directed and executive produced the pilot .", "label": "", "metadata": {}, "score": "122.57738"}
{"text": "H influenzae type b can cause invasive disease such as meningitis and sepsis .19,20 These levels have been used to evaluate the effectiveness of Haemophilus b Conjugate Vaccines , including the ActHIB vaccine component of Pentacel vaccine .", "label": "", "metadata": {}, "score": "122.80493"}
{"text": "They seem to forget it is called The Sarah Conner Chronicles so it should focus on Sarah and John with Cameron being a supporting character .", "label": "", "metadata": {}, "score": "123.93024"}
{"text": "Pentacel .CLINICAL PHARMACOLOGY .Mechanism Of Action .Diphtheria .Diphtheria is an acute toxin -mediated disease caused by toxigenic strains of C diphtheriae .", "label": "", "metadata": {}, "score": "125.245316"}
{"text": "In case you do n't know Terminator - The Sarah Conner Chronicles ( aka TTSCC ) is part of the Terminator movie franchise started by James Cameron with his movie Terminator in 1984 .", "label": "", "metadata": {}, "score": "126.46753"}
{"text": "There are two other supporting characters .One is Cameron - a reprogrammed female Terminator sent back to protect the teen aged John Conner .The other was Derrick Reese - brother of Kyle , John 's father .", "label": "", "metadata": {}, "score": "127.93571"}
{"text": "Now , here , you see , it takes all the running you can do , to keep in the same place .If you want to get somewhere else , you must run at least twice as fast as that ! '", "label": "", "metadata": {}, "score": "128.22577"}
{"text": "Tetanus is an acute disease caused by an extremely potent neurotoxin produced by C tetani .Protection against disease is due to the development of neutralizing antibodies to tetanus toxin .", "label": "", "metadata": {}, "score": "128.98663"}
{"text": "A very ingenious plot device that was heart warming and sad all at the same time . \" Terminator : The Sarah Connor Chronicles \" is not so dead after all .", "label": "", "metadata": {}, "score": "130.67044"}
{"text": "What I liked about the story was the future war and John Conner .The films showed a bit of that war and glimpes of John Conner .", "label": "", "metadata": {}, "score": "131.1523"}
{"text": "Last reviewed on RxList : 11/13/2015 This monograph has been modified to include the generic and brand name in many instances .Syfy has given a series order to 12 Monkeys , a drama based on the 1995 Universal Pictures film directed by Terry Gilliam .", "label": "", "metadata": {}, "score": "131.72417"}
{"text": "Reading some of the comments from the past few episodes left me gob smacked and I hope if I ever act that way , that someone slap me upside the head .", "label": "", "metadata": {}, "score": "133.48726"}
{"text": "It sends a Terminator ( a human like cyborg ) back in time to kill the mother of the leader of the human resistance .Her name is Sarah Conner .", "label": "", "metadata": {}, "score": "137.1236"}
{"text": "and Atlas Entertainment , producer of the movie , follows the journey of a time traveler ( Aaron Stanford ) from the post - apocalyptic future who appears in present day on a mission to locate and eradicate the source of a deadly plague that will eventually decimate the human race .", "label": "", "metadata": {}, "score": "137.69476"}
{"text": "2 Appearances by Republican former elected officeholders . 1 Appearance by a Bush Cabinet Secretary .T. Boone Pickens Ted Turner .Please , stop hurting the country with your concern troll , faux \" objective \" analysis of the speeches and events at the convention .", "label": "", "metadata": {}, "score": "138.80922"}
{"text": "Pertussis .Pertussis ( whooping cough ) is a respiratory disease caused by B pertussis .This Gram - negative coccobacillus produces a variety of biologically active components , though their role in either the pathogenesis of , or immunity to , pertussis has not been clearly defined .", "label": "", "metadata": {}, "score": "144.593"}
{"text": "The actress who plays Cameron - Summer Glau - has her own fan base from her previous role in the TV show Firefly and those fan think that TTSCC should focus more on Cameron .", "label": "", "metadata": {}, "score": "145.41786"}
